Aarti Drugs has rallied 11% to Rs 1,335 on BSE in early morning trade after the pharmaceutical company announced an issue of bonus shares in a ratio of 1:1 and a strong set of numbers for the quarter ended December 31, 2014 (Q3).
The stock opened at Rs 1,324 and touched a new high of Rs 1,345 on BSE. A combined around 10,000 shares changed hands till 0917 hours on BSE and NSE.
“Announcement of bonus equity shares by capitalization of reserves & surplus including securities premium account to the existing shareholders of the company in proportion of 1:1 i.e. 1 (one) bonus equity share of Rs 10 each fully paid up for every 1 (one) existing equity share of Rs. 10 each fully paid up held in the company on the 'Record Date' to be fixed in this behalf in due course,” Aarti Drugs said in a statement.
The board has also declared second interim dividend Rs 5 per share for the financial year 2014-2015, it added.
Meanwhile, the company has reported a strong 61% year on year (yoy) jump in net profit at Rs 22.75 crore for Q3FY15. The company had profit of Rs 14.16 crore in a year ago quarter.
Net sales grew 17% at Rs 260 crore on yoy basis.
The stock opened at Rs 1,324 and touched a new high of Rs 1,345 on BSE. A combined around 10,000 shares changed hands till 0917 hours on BSE and NSE.
“Announcement of bonus equity shares by capitalization of reserves & surplus including securities premium account to the existing shareholders of the company in proportion of 1:1 i.e. 1 (one) bonus equity share of Rs 10 each fully paid up for every 1 (one) existing equity share of Rs. 10 each fully paid up held in the company on the 'Record Date' to be fixed in this behalf in due course,” Aarti Drugs said in a statement.
The board has also declared second interim dividend Rs 5 per share for the financial year 2014-2015, it added.
Meanwhile, the company has reported a strong 61% year on year (yoy) jump in net profit at Rs 22.75 crore for Q3FY15. The company had profit of Rs 14.16 crore in a year ago quarter.
Net sales grew 17% at Rs 260 crore on yoy basis.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%